A grand kick-off meeting was held for the โLast Mile Authorization Ethiopiaโ project, aimed at strengthening the EFDAโs abridged review process based on the reliance pathway.
During the official kick-off of the drug evaluation, registration, and market authorization process on March 28, 2025, the Chief Executive Officer of EFDA, Abayneh Alemayehu, emphasized the significance of the project in enhancing the current registration system. He also expressed gratitude to the Gates Foundation for its financial support, which has been instrumental in enabling the registration and importation of various medicines. This support has helped address critical gaps in the market authorization process, which previously relied on data from well-established regulatory bodies.
the project will reduce the workload and improve efficiency by significantly shortening the approval timelines for essential medicines. In addition, the project will focus on capacity building for dossier assessors, experience-sharing, and collaborative discussions to establish systems that support further collaboration in the reliance system.
